Skip to content
Review

Implementation and evaluation of pharmacogenomics alerts for high-risk drug-gene interactions in a community pharmacy practice setting.

Aug 2026 · Journal of the American Pharmacists Association · pp. 103501 · 0 citations
Medicine

TL;DR

PGx alerts in the medication dispensing module provide an additional safeguard for precision medicine, enabling pharmacists to make targeted interventions and provide patient education.

Abstract

Background

Integration of pharmacogenomics (PGx) into clinical care has primarily occurred within academic medical centers. Clinical decision support (CDS) is vital to the incorporation of PGx into clinical care, however, efforts have not capitalized on the integration within community pharmacy settings.

Objective

To describe the implementation efforts for community pharmacy CDS alerts and assess effectiveness.

Methods

A retrospective manual chart review was conducted to evaluate the effectiveness of deploying PGx alerts across 14 community pharmacies within a single health system. A report was created to capture all PGx CDS alerts generated during the eight-month study period (October 2024-May 2025). Alerts were categorized as actionable when documentation was sparse for medication adjustments based on PGx results from the prescribing clinician upon transmission of the prescription to the community pharmacy.

Results

A total of 74 alerts were generated, of which 36 were unique alerts. Thirty-eight alerts were excluded as duplicates when the pharmacist re-entered the dispensing function. Clinicians adjusted 17 chemotherapy prescriptions prior to order transmission. Additionally, five alerts for chemotherapy medications were considered not actionable as the patient had previously tolerated therapy. The remaining 13 alerts comprised of 11 for clopidogrel and 2 for tramadol. Pharmacists intervened in 8 of the 11 clopidogrel orders which resulted in 3 medication modifications. The overall alert acceptance was 23%.

Conclusion

This study describes one of the first institutions to deploy PGx alerts through the community pharmacy module across a health system's electronic health record. PGx alerts in the medication dispensing module provide an additional safeguard for precision medicine, enabling pharmacists to make targeted interventions and provide patient education. Continuous evaluation of PGx alerts affords opportunities for alert refinement and further optimizing patient care.

View source

Similar papers

Review Open access Sep 2026

850. Clinical implementation of pharmacogenomics in the United States

It is demonstrated that PGx testing may decrease polypharmacy, which may also reduce not only the number of drug–drug interactions, but also the cost to healthcare systems and patients.

A. Halaris · 0 citations
Review Open access Aug 2026

Pharmacogenomics in Primary Care: A Narrative Review of DNA-Guided Prescribing in Multimorbidity and Polypharmacy

Pharmacogenomics can convert stable DNA variation into prescribing information, but its value in primary care depends on whether a result changes a decision at the right moment. This narrative review critically examines selected actionable gene–drug pairs, implementation models, conflicting evidence, and unresolved que...

Luis E. Martínez-Tittonel · 0 citations
Review Oct 2026

Pharmacogenomics utilization as a tool for deprescribing in Veterans at high-risk for polypharmacy.

BACKGROUND Pharmacogenomics (PGx) assesses how genetic variation influences medication response and can support medication optimization. For patients with substantial medication burden, optimization efforts are essential for improving medication safety. At the Madison VA, Veterans identified through a polypharmacy dash...

Lauren Collier Murray, Erica Farina, L. Welch et al. · 0 citations
Review Aug 2026

Current knowledge and use of pharmacogenomics among NPs: An integrative review.

BACKGROUND Pharmacogenomics, a critical component of precision medicine, is rapidly transforming health care by tailoring drug therapy based on individual genetic profiles. Nurse practitioners (NPs), as frontline providers and prescribers, play a key role in implementing pharmacogenomics into clinical practice. Despite...

Danielle Whitten, Mackenzie Courtney, Morgan Courtney et al. · 0 citations
Review Open access Sep 2026

Pharmacogenomics in Emergency Care: Actionable Genetic Variability, Drug-Related Toxicity, and Precision Prescribing

Pharmacogenomic variability represents an increasingly relevant determinant of therapeutic response, drug toxicity, and treatment failure in emergency and internal medicine. This study analyzed the clinical applicability of actionable gene–drug interactions associated with acute pharmacological decision-making, severe...

Dayanna Estefania Fernández Astudillo, Cristian David Castro Hernandez, María Alejandra Galindo Van Strahlen et al. · 0 citations
#software testing Review Open access Aug 2026

Clinical relevance of pharmacogenomic information for improving prescribing practices in acutely admitted older medical patients.

It is suggested that PGx information may have meaningful clinical utility for improving prescribing practices in acute care, however, interpretation in this population requires careful consideration of other factors such as nutritional status and inflammation that may modify pharmacogene activity.

L. W. Christensen, A. K. Boas, Emilie Clausen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.